Who Paid My Doc
Jordan Schramm
Pediatric Otolaryngology Provo, UT Medical Doctor
NPI 1588976328 CMS profile 1063251
1055 N 300 W Ste 401, Provo, UT 84604
General payments
$180,527
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$157,965
Through program year 2025, Jordan Schramm of Provo, UT is reported in the CMS Open Payments database as having received $180,527 across 266 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $157,965 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Pediatric Otolaryngology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $73,196 | 85 | |
| 2024 | General | $57,844 | 86 | |
| 2023 | General | $32,414 | 51 | |
| 2022 | General | $16,065 | 32 | |
| 2021 | General | $23 | 2 | |
| 2020 | General | $37 | 3 | |
| 2019 | General | $948 | 7 |
Beside peers
- Jordan Schramm
- Pediatric Otolaryngology median
- Middle half of Pediatric Otolaryngology
- National median
In program year 2025, general payments to Jordan Schramm were reported at $73,196. Among 368 Pediatric Otolaryngology profiles paid that year, the median was $172 and the middle half received between $78 and $412.
Show as a table
| Year | Jordan Schramm | Pediatric Otolaryngology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $948 | $127 | $51–$271 | $163 |
| 2020 | $37 | $64 | $31–$165 | $114 |
| 2021 | $23 | $88 | $26–$225 | $132 |
| 2022 | $16,065 | $122 | $43–$316 | $149 |
| 2023 | $32,414 | $128 | $52–$340 | $160 |
| 2024 | $57,844 | $150 | $65–$384 | $164 |
| 2025 | $73,196 | $172 | $78–$412 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
266 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Otolaryngology in Utah
Albert Park
Pediatric Otolaryngology · Salt Lake City, UT
Phillip Chaffin
Pediatric Otolaryngology · Provo, UT
Paul Krakovitz
Pediatric Otolaryngology · Salt Lake City, UT
Steven Kelly
Pediatric Otolaryngology · Bountiful, UT
Johannes Grimmer
Pediatric Otolaryngology · Salt Lake City, UT
Marshall Smith
Pediatric Otolaryngology · Salt Lake City, UT
Related records
Pediatric Otolaryngology in Utah
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Otolaryngology
Everyone recorded under this specialty, nationwide.
Doctors in Utah
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.